This article in Lawyers.com?áexplores the privacy rights ramifications of a New York criminal court’s ruling that Twitter must comply with a subpoena and turn over a user’s tweets.?á Providing commentary in the piece?áis our Social Media Practice Group Chair David Bell.
For more than fifteen years, the U.S. Food and Drug Administration has struggled to craft a policy on how the Internet may be used to promote medical products. Now, the FDA has a firm deadline: July 9, 2014. On Monday, President Obama signed into law a bill that will require the FDA to finally state its policy on use of the Internet ?Çô including social media ?Çô to promote medical products that are regulated by the FDA. Under Section 1121 of the bill, the FDA has two years from the date the bill was signed into law to issue the new guidelines. The provision is one of several ?Ç£Miscellaneous Provisions?Ç¥ in a bill that reauthorizes the FDA to collect user fees from drug companies and creates new user fee programs for generic drug manufacturers. The FDA has been deliberating on the subject of online drug promotion since as early as… Continue Reading